These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13194680)

  • 1. Uric acid in two patients with Wilson's disease (hepatolenticular degeneration).
    BISHOP C; ZIMDAHL WT; TALBOTT JH
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):440-1. PubMed ID: 13194680
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
    Umeki S; Ohga R; Konishi Y; Yasuda T; Morimoto K; Terao A
    Am J Med Sci; 1986 Nov; 292(5):289-92. PubMed ID: 3777013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a urate reabsorptive defect in patients with Wilson's disease.
    Wilson DM; Goldstein P
    Adv Exp Med Biol; 1974; 41():729-37. PubMed ID: 4832602
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of risk factors for fatty liver disease in children with Wilson's disease.
    Jia SP; Wang MX; Tao Z; Gao YN; Yu GR; Yang WM
    Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1046-1053. PubMed ID: 38874972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalciuria in hepatolenticular degeneration (Wilson's disease).
    Randall RV; Goldstein NP; Gross JB; Rosevear JW
    Am J Med Sci; 1966 Dec; 252(6):715-20. PubMed ID: 5954673
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Correlation between Blood Uric Acid and Goldstein Grading in Hepatolenticular Degeneration Patients with Different Chinese Medical Syndrome Types].
    Hu JY; Han YZ; Ye QR; Hong MF; Cai YL; Ren MS; Pan FM; Wang X; Yang RM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Nov; 35(11):1335-9. PubMed ID: 26775481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; GITLIN D
    Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of penicillamine therapy on uric acid metabolism in Wilson's disease.
    Sorensen LB; Kappas A
    Trans Assoc Am Physicians; 1966; 79():157-64. PubMed ID: 5954284
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal urate excretion in patients with Wilson's disease.
    Wilson DM; Goldstein NP
    Kidney Int; 1973 Nov; 4(5):331-6. PubMed ID: 4762580
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal impairment in different phenotypes of Wilson disease.
    Wang H; Zhou Z; Hu J; Han Y; Wang X; Cheng N; Wu Y; Yang R
    Neurol Sci; 2015 Nov; 36(11):2111-5. PubMed ID: 26219584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of the relation of ceruloplasmin to Wilson's disease.
    SCHEINBERG IH; HARRIS RS; MORELL AG; DUBIN D
    Neurology; 1958 Apr; 8(Suppl 1):44-51. PubMed ID: 13541603
    [No Abstract]   [Full Text] [Related]  

  • 15. Caeruloplasmin in Wilson's disease.
    ROSENOER VM; FRANGLEN G
    Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
    Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
    J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 18. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 19. A rapid screening test for deficiency of plasma ceruloplasmin and its value in the diagnosis of Wilson's disease.
    AISEN P; SCHORR JB; MORELL AG; GOLD RZ; SCHEINBERG IH
    Am J Med; 1960 Apr; 28():550-4. PubMed ID: 13792199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage].
    Degli Esposti A; Antener I; Ambrosioni G; Bonfiglioli G
    Minerva Pediatr; 1976 Nov; 28(34):2063-86. PubMed ID: 1012227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.